For its third fiscal quarter (ending September 30), Harte Hanks Inc. (NASDAQ: HHS) has reported a -90% decline in E.P.S. from $0.87 a year ago to $0.09 in the current quarter. This performance was $-0.09 short of the consensus estimate of $0.18. For the latest four quarters through September 30, E.P.S. were $2.87 versus $2.01 for the same period a year ago — an increase of 43%.
Recent Price Action
On 11/9/23, Harte Hanks Inc. (NASDAQ: HHS) stock rose modestly by 0.9%, closing at $7.08. Relative to the market the stock has been extremely weak over the last nine months but has risen 8.1% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, HHS is expected to continue to be a major Value Builder.
Harte Hanks has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Harte Hanks has a slightly negative Appreciation Score of 37 and a very low Power Rating of 3, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this discouraging new earnings information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment